Embracing the digital era in this poster, using a myeloma treatments scheduler Andrea Preston BSH - Haematology Myeloma UK #BSH2025

Matt Jenner did a great job of summarising our soon to be published BSH - Haematology guidelines on the management of relapsed myeloma at #BSH2025 #mmsm

#Myeloma Paper of the Day: Revised free light chain reference intervals that reclassified 32% of pts as normal (their hazard ratio for PD was 1.07, 95% confidence interval 0.74-1.57) enhance risk stratification in #MGUS and reduce overdiagnosis: pubmed.ncbi.nlm.nih.gov/40295472/. #mmsm

Excellent session on frailty and myeloma BSH - Haematology. Inspiring, entertaining and practice changing talks delivered by Gordon Cook Annie Mac 🏳️‍🌈 and Salomon Mainer from IFM. Take home message: stop Dex early! #downwithdex #mmsm

The inaugural meeting of ⁦Irish Multiple Myeloma Society⁩ will take place September 12th in Dublin. Open to HCPs/trainees working with myeloma patients, a wonderful panel of speakers promises to make this a great meeting 🇮🇪 #mmsm

There is a real urgency to get it right for older adults across health & social care. These resources based on Ageing & Frailty standards enable that improvement journey. We need to work as a focused & integrated teams to deliver this around Scotland #frailty

Blood Cancer UK investing in exciting research over next 5 years, says chief exec Helen Rowntree. Such encouraging news, Helen! #HPCC25 Blood Cancer UK

REGISTRATION IS OPEN FOR #ESHMM2026 March 26-28, 2026 / Stockholm, Sweden 8th Translational Research Conference Multiple Myeloma Chairs : Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch, MD, PhD To register & for more information 👉bit.ly/4cy6PCW #ESHCONFERENCES #MMsm #HAEMATOLOGY

A fantastic day at the Sanius Healthcare Professional and Patient conference today.Our session highlighted many important considerations for patients to think about when going on a trial and some pertinent issues around diversity in clinical trials Andrea Preston

Solitary plasmacytoma. One lesion, but 3 possible entities with differing prognosis in the differential diagnosis. Outcomes and management. ⁦Mayo Myeloma⁩ ⁦Blood Advances⁩ ⁦ASH⁩ ashpublications.org/bloodadvances/…

Another important contribution to the debate on limiting lenalidomide maintenance post-ASCT. Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma ashpublications.org/blood/article/…

A opportunity to join our research team - Haematology trainees interested in plasma cell disorders - DM if interested UK Myeloma Society BSH - Haematology ASH

Looking forward to speaking on treatment of High-risk #myeloma at European Hematology Association conference in Milano in June - many thanks Myeloma Society and EHA for invite. In the meantime, hope people might enjoy our BSH - Haematology podcast on this topic: podbean.com/ew/pb-2734e-17…

Reminder to BOPA Committee, APTUK and UKONS …6 days to IMS abstract deadline …. A fantastic opportunity to showcase your amazing work 💥💥

@EHA plenary session - ⁦Rakesh Popat⁩ presenting JNJ-5322 - a trispecific antibody in relapse refractory myeloma. A new potential step change for RR MM

Rakesh Popat flying the flag for the UK Myeloma community with a presentation of very impressive results with the use of trispecific antibody JNJ-5322 in the Plenary session at #EHA2025

Honored to present tomorrow at EHA Milan!Gold Hall at 11 am Sunday June 15 All but one patient responded!Amaizing data which will be the experimental arm of an upcoming randomized study in ND NTE MM patients

Late breaking abstract 📢 Tec + Tal showing high response in EMD with strict central response assessments. Good to see dual antigen targeting making a difference in this high risk group. #mmsm #EHA2025

Kwee Yong from UCL Cancer Institute making the case we need to understand the biology of smouldering myeloma better to pick the right intervention. #EHA2025

1/2 Many people living with myeloma experience symptoms for months or even years before receiving a diagnosis. By sharing this post, you can help raise awareness and make sure more people recognise the warning signs sooner ⚠️ #MyelomaAwarenessWeek #MyelomaWarningSigns